Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate CancerEur Urol 2021 Oct 26;[EPub Ahead of Print], RP Graf, V Fisher, J Mateo, OV Gjoerup, RW Madison, K Raskina, H Tukachinsky, J Creeden, R Cunningham, RSP Huang, DA Mata, JS Ross, GR Oxnard, JM Venstrom, AJ Zurita
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.